Affinity Asset Advisors »

Galecto shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Galecto (DMRA) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galecto by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 450k 25.90

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Galecto

FMR
Fairmount Funds Management
venBio Select Advisor
VR Adviser
Fcpm Iii Services B.v.
RA Capital Management
Henderson Group
Viking Global Investors
Bellevue Group
Remedium Capital Partners
Commodore Capital
Cormorant Asset Management
Balyasny Asset Management
AH Capital Management
Perceptive Advisors

View all funds holding Galecto